• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯合子家族性高胆固醇血症患者的长期随访;一家大学医院脂质门诊的13年经验

[Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic].

作者信息

Kayıkçıoğlu Meral, Kısmalı Erkan, Can Levent, Payzin Serdar

机构信息

Department of Cardiology, Ege University Faculty of Medicine, İzmir, Turkey.

Department of Radiology, Ege University Faculty of Medicine, İzmir, Turkey.

出版信息

Turk Kardiyol Dern Ars. 2014 Oct;42(7):599-611. doi: 10.5543/tkda.2014.09633.

DOI:10.5543/tkda.2014.09633
PMID:25490294
Abstract

OBJECTIVES

Familiar hypercholesterolemia (FH) is a genetic disease characterized with extremely high levels of cholesterol leading to premature atherosclerosis. In homozygous individuals (HoFH) cardiovascular events could develop in childhood. In this article, long-term clinical experience with adult HoFH patients who are followed in Department of Cardiology, Ege University Faculty of Medicine is presented.

STUDY DESIGN

Seventeen HoFH patients (11 females, 6 males) who are being followed between the years 2000-2013 were included. All data including clinical characteristics, family history, lipid levels, treatment, lipid-apheresis, cardiovascular events, complications were obtained retrospectively from patient chart records.

RESULTS

Mean age was 31 ± 10 years at admission to our clinic. First diagnosis age was 25 ± 14. At diagnosis, mean cholesterol level was 625 ± 136 mg/dl. Admission complaints were dermatologic (41%) and ischemic symptoms (41%). A total of 3 patients (18%) were diagnosed during family screening. 65% of the patients' parents had consanguineous marriage. Xantomas was present in 59%, aortic valve pathology in 59%, and carotid artery plaques in 47%. Coronary artery disease was documented in 59%. Though all patients had indication for apheresis, 10 patients received apheresis due to high refusal rate. Age at the first apheresis was 27 ± 12 (minimum 10-maximum 42) and adherence to apheresis was 60%. With 2 years regular apheresis skin depositions were vanished, however carotid atherosclerosis and aortic pathology progressed. During the 43 ± 42 months follow-up, 4 patients died (mean age: 25 ± 5).

CONCLUSION

Diagnosis is late in HoAH. Due to the delayed treatment of lipid apheresis, atherosclerosis and aortic stenosis progress in these patients. The awareness of the physicians and knowledge of the public is warranted.

摘要

目的

家族性高胆固醇血症(FH)是一种遗传性疾病,其特征是胆固醇水平极高,可导致早发性动脉粥样硬化。在纯合子个体(HoFH)中,心血管事件可在儿童期发生。本文介绍了伊兹密尔艾杰大学医学院心脏病科对成年HoFH患者的长期临床经验。

研究设计

纳入了2000年至2013年间随访的17例HoFH患者(11例女性,6例男性)。所有数据,包括临床特征、家族史、血脂水平、治疗、血脂分离、心血管事件、并发症等,均从患者病历记录中回顾性获取。

结果

患者入院时的平均年龄为31±10岁。首次诊断年龄为25±14岁。诊断时,平均胆固醇水平为625±136mg/dl。入院主诉为皮肤症状(41%)和缺血症状(41%)。共有3例患者(18%)在家族筛查中被诊断。65%的患者父母为近亲结婚。59%的患者有黄色瘤,59%有主动脉瓣病变,47%有颈动脉斑块。59%的患者有冠状动脉疾病记录。尽管所有患者都有进行血脂分离的指征,但由于拒绝率高,10例患者接受了血脂分离。首次进行血脂分离的年龄为27±12岁(最小10岁 - 最大42岁),血脂分离的依从率为60%。经过2年的定期血脂分离,皮肤沉积物消失,但颈动脉粥样硬化和主动脉病变仍有进展。在43±42个月的随访期间,4例患者死亡(平均年龄:25±5岁)。

结论

HoAH的诊断较晚。由于血脂分离治疗延迟,这些患者的动脉粥样硬化和主动脉狭窄仍在进展。医生的意识和公众的认知都有待提高。

相似文献

1
[Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic].纯合子家族性高胆固醇血症患者的长期随访;一家大学医院脂质门诊的13年经验
Turk Kardiyol Dern Ars. 2014 Oct;42(7):599-611. doi: 10.5543/tkda.2014.09633.
2
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.脂蛋白吸附治疗起始于儿童期的纯合子家族性高胆固醇血症患者的心血管结局:来自两个登记处的国际队列的长期随访。
Lancet Child Adolesc Health. 2024 Jul;8(7):491-499. doi: 10.1016/S2352-4642(24)00073-7. Epub 2024 May 14.
3
[Homozygous familial hypercholesterolemia].纯合子家族性高胆固醇血症
Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 2:19-31.
4
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.家族性高胆固醇血症纯合子患者的血浆分离术:所有家族性高胆固醇血症纯合子挪威患者的随访结果。
J Clin Lipidol. 2012 Jul-Aug;6(4):331-9. doi: 10.1016/j.jacl.2012.03.004. Epub 2012 Mar 23.
5
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).土耳其接受 LDL 吸附治疗的纯合子家族性高胆固醇血症患者的全国性调查(A-HIT 1 注册研究)。
Atherosclerosis. 2018 Mar;270:42-48. doi: 10.1016/j.atherosclerosis.2018.01.034. Epub 2018 Jan 31.
6
The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.土耳其全国家族性高胆固醇血症登记处的基本原理与设计:A-HIT1和A-HIT2研究
Turk Kardiyol Dern Ars. 2017 Apr;45(3):261-267. doi: 10.5543/tkda.2017.25800.
7
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.纯合子家族性高胆固醇血症患者的临床和分子特征:来自SAFEHEART注册研究的见解
J Clin Lipidol. 2016 Jul-Aug;10(4):953-961. doi: 10.1016/j.jacl.2016.04.006. Epub 2016 Apr 21.
8
Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.一名家族性高胆固醇血症患者在接受长期积极的低密度脂蛋白单采胆固醇降低治疗后,出现明显的主动脉瓣狭窄进展。
Circ J. 2009 May;73(5):963-6. doi: 10.1253/circj.cj-08-0164. Epub 2008 Dec 16.
9
Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.家族性高胆固醇血症以及美国患者在接受最大耐受降脂治疗后适合进行低密度脂蛋白去除术的评估。
J Clin Lipidol. 2014 Jan-Feb;8(1):18-28. doi: 10.1016/j.jacl.2013.11.002. Epub 2013 Nov 8.
10
Coronary artery bypass grafting in familial hypercholesterolemia.家族性高胆固醇血症的冠状动脉搭桥术
J Thorac Cardiovasc Surg. 1995 Feb;109(2):364-9. doi: 10.1016/S0022-5223(95)70398-5.

引用本文的文献

1
Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study.血清代谢物与高胆固醇血症:一项两样本孟德尔随机化研究的见解
Front Cardiovasc Med. 2024 Jul 25;11:1410006. doi: 10.3389/fcvm.2024.1410006. eCollection 2024.
2
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications.调脂药物及其他药物对脂蛋白(a)水平的影响——重大临床意义
Pharmaceuticals (Basel). 2023 May 16;16(5):750. doi: 10.3390/ph16050750.
3
Case report: Therapy adherence, variants, and course of atheroma in two patients with HoFH on low-dose, long-term lomitapide therapy.
病例报告:两名纯合子家族性高胆固醇血症患者接受低剂量、长期洛美他派治疗时的治疗依从性、变异情况及动脉粥样硬化病程
Front Genet. 2023 Jan 4;13:1087089. doi: 10.3389/fgene.2022.1087089. eCollection 2022.
4
Current Treatment Options in Homozygous Familial Hypercholesterolemia.纯合子家族性高胆固醇血症的当前治疗选择
Pharmaceuticals (Basel). 2022 Dec 31;16(1):64. doi: 10.3390/ph16010064.
5
Premature Myocardial Infarction: A Rising Threat.早发性心肌梗死:日益严峻的威胁。
Balkan Med J. 2022 Mar 14;39(2):83-95. doi: 10.4274/balkanmedj.galenos.2022-2-19.
6
Familial Hypercholesterolemia: Global Burden and Approaches.家族性高胆固醇血症:全球负担与方法。
Curr Cardiol Rep. 2021 Sep 4;23(10):151. doi: 10.1007/s11886-021-01565-5.
7
Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia.新冠疫情对纯合子家族性高胆固醇血症管理造成的附带损害。
J Clin Lipidol. 2021 Mar-Apr;15(2):381-382. doi: 10.1016/j.jacl.2021.02.003.
8
Lipoprotein apheresis efficacy and challenges: single center experience.脂蛋白分离术的疗效与挑战:单中心经验
Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):56-62. doi: 10.1016/j.htct.2021.01.009. Epub 2021 Mar 14.
9
LDL Apheresis and Lp (a) Apheresis: A Clinician's Perspective.LDL 血浆吸附治疗和 Lp(a) 血浆吸附治疗:临床医生视角。
Curr Atheroscler Rep. 2021 Feb 17;23(4):15. doi: 10.1007/s11883-021-00911-w.
10
Premature Coronary Artery Disease due to Homozygous Familial Hypercholesterolemia in a 12-Year-Old Girl.12 岁女孩因纯合子家族性高胆固醇血症导致的早发性冠状动脉疾病。
Balkan Med J. 2018 Mar 15;35(2):208-211. doi: 10.4274/balkanmedj.2017.0490. Epub 2017 Oct 26.